{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:01Z","timestamp":1786649521068,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the dosimetric parameters in hybrid brachytherapy with and without using the vaginal component for carcinoma cervix patients that do not have disease extending to the vagina.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Patients without vaginal involvement who received chemoradiation and hybrid brachytherapy were prospectively included for analysis. Two plans were created for each patient. The first plan (Plan 1) was created by loading the interstitial component to 10\u201320% of the tandem loading and reducing the vaginal loading to 30%. The second plan (Plan 2) was created by loading the tandem and interstitial component only and eliminating the vaginal loading (ovoid\u2019s). The dose delivered with brachytherapy was 21 Gy in 3 fractions. The dosimetric parameters compared between the two plans were D90 HRCTV, D98 IRCTV, TRAK, D2cc to bladder, rectum, sigmoid, and dose to the ICRU 89 RV point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Thirty patients were included for analysis. The mean HRCTV volume was 30 cc. The mean D90 HRCTV was 88.1 Gy EQD2 for Plan 1 vs 87.8 Gy EQD2 for Plan 2, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.113). On statistical analysis, there was a significant difference between Rectum D2cc (72.4 Gy vs 67.3 Gy) and ICRU 89 RV point dose (71.3 Gy vs 61.2 Gy) between the two plans (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001). The mean D2cc to bladder and sigmoid was similar between the two plans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In carcinoma cervix patients without vaginal involvement, omission of vaginal loading in tandem and ovoid hybrid brachytherapy reduces rectum and RV point doses while maintaining target coverage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_568_24","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T11:00:24Z","timestamp":1751713224000},"page":"606-610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Dosimetric implications of omitting vaginal loading in hybrid brachytherapy for carcinoma cervix without vaginal infiltration"],"prefix":"10.4103","volume":"21","author":[{"given":"Devender Reddy","family":"Boja","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"},{"name":"Department of Physics, University College of Science, Osmania University, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjot Kaur","family":"Bajwa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, American Oncology of Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N V N Madhusudhana","family":"Sresty","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnam Raju","family":"Alluri","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, American Oncology of Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hima Bindu","family":"Pitta","sequence":"additional","affiliation":[{"name":"Department of Physics, University College of Science, Osmania University, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynecological (GYN) GEC-ESTRO working group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother Oncol"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"624e630","DOI":"10.1016\/j.ijrobp.2006.01.036","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning and dosimetric results","volume":"65","author":"Kirisits","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2011.04.044","article-title":"Clinical use of the Utrecht applicator for combined intracavitary\/interstitial brachytherapy treatment in locally advanced cervical cancer","volume":"82","author":"Nomden","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","article-title":"Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study","volume":"120","author":"Fokdal","year":"2016","journal-title":"Radiother Oncol"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2006.04.041","article-title":"The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results","volume":"66","author":"Dimopoulos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2022.06.019","article-title":"Clinical outcome of combined intracavitary\/interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer","volume":"166","author":"Rogowski","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R8-20250707","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.radonc.2010.01.001","article-title":"From point a to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer","volume":"94","author":"Tanderup","year":"2010","journal-title":"Radiother Oncol"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2013.01.010","article-title":"Clinical feasibility of combined intracavitary\/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem\/ring applicator in situ and virtual preplanning of the interstitial component","volume":"107","author":"Fokdal","year":"2013","journal-title":"Radiother Oncol"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.radonc.2016.05.020","article-title":"Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer","volume":"120","author":"Mohamed","year":"2016","journal-title":"Radiother Oncol"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5114\/jcb.2023.124399","article-title":"Are active dwell positions always necessary in the ring\/ovoids channel of the cervical applicator in the intracavitary-interstitial brachytherapy of cervical cancer?","volume":"15","author":"Fr\u00f6hlich","year":"2023","journal-title":"J Contem Brachytherapy"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: Results from the EMBRACE I study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.brachy.2012.11.001","article-title":"Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: Treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicen","volume":"12","author":"Nkiwane","year":"2013","journal-title":"Brachytherapy"},{"key":"R14-20250707","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_568_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:59Z","timestamp":1786647299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_568_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_568_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-03-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}